HPV DNA test could slash cervical cancer deaths in High-Risk populations

NCT ID NCT02956031

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study evaluates whether an HPV DNA test can more accurately detect pre-cancerous cervical changes than standard Pap smears in 1,500 women in South Africa, including those with and without HIV. Participants undergo HPV testing, followed by colposcopy and biopsy if needed. The goal is to see if this approach improves early detection and could be used for national screening programs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HPV DNA test
What this could lead to
If successful, this screening method could reduce cervical cancer deaths by catching pre-cancer earlier, especially in regions with high HIV rates.
What could go wrong
This is a diagnostic study, not a treatment trial. The screening test may still miss some cases or lead to unnecessary follow-up procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Steve Biko Academic Hospital

    RECRUITING

    Pretoria, Gauteng, South Africa

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.